CLINICAL UTILITY OF RETICULOCYTE INDICES IN THE DIAGNOSIS AND MANAGEMENT OF PAEDIATRIC SICKLE CELL DISEASE PATIENTS IN PORT HARCOURT, NIGERIA

Zaccheaus Jeremiah; Choice Odozi; Bliss Jeremiah; Chioma Okechukwu

doi:10.5937/sanamed0-58242

Zaccheaus Jeremiah Rivers State University, Faculty of Medical Laboratory Science, Department of Haematology and Blood Transfusion Science, Port Harcourt, Nigeria
Choice Odozi Rivers State University teaching hospital, Department of Paediatrics and Child Health, Port Harcourt, Nigeria
Bliss Jeremiah Rivers State University teaching hospital, Department of Paediatrics and Child Health, Port Harcourt, Nigeria
Chioma Okechukwu Rivers State University teaching hospital, Department of Paediatrics and Child Health, Port Harcourt, Nigeria

DOI: https://doi.org/10.5937/sanamed0-58242

Keywords: Sickle Cell Anaemia, hydroxyurea, reticulocyte count, reticulocyte production index, hypoproliferative anaemia, absolute reticulocyte count

Abstract

Introduction:Sickle cell anemia (SCA) is a hereditary blood disorder resulting from a point mutation in the β-globin gene, leading to the production of abnormal hemoglobin S that distorts red blood cell morphology and impairs their function. Reticulocyte indices, which measure immature red blood cells in circulation, are key indicators of bone marrow response and erythropoietic activity in SCA patients.

Materials and Methods: This cross-sectional study examined reticulocyte indices in individuals with sickle cell anemia. It involved 45 children aged 2 to 19 at the Rivers State University Teaching Hospital. Blood samples were collected from each patient and placed in EDTA bottles. Reticulocyte counts were performed using the New Methylene Blue staining method and counted under a light microscope. Hemoglobin (Hb) and packed cell volume (PCV) were measured with a Veri-Q RED Hemoglobin meter. Reticulocyte indices, including absolute reticulocyte count (ARC), reticulocyte index (RI), and reticulocyte production index (RPI), were calculated using MDCalc.

Results: The mean reticulocyte count was 1.33 ± 0.22%, while the mean reticulocyte production index was 0.40 ± 0.09. Reticulocyte production index (RPI) showed a positive and significant correlation with Hb and PCV in both crisis and steady states (r = 0.820, p = 0.02). Additionally, RPI and RC were significantly correlated in patients on and off hydroxyurea (p < 0.01). Only 2 (4.4%) SCA patients demonstrated appropriate bone marrow response, while the remaining 43 (95.6%) SCA patients were hypoproliferative.

Conclusion: This study found derangements in the reticulocyte parameters indicating hypoproliferative anaemia. There is a need to monitor the patients closely by periodic reticulocyte counts for overall improved patient outcomes and quality of life in SCA patients.

References

Elendu C, Amaechi DC, Alakwe-Ojimba CE, Elendu TC, Elendu RC, Ayabazu CP, et al. Understanding Sickle cell disease: causes, symptoms, and treatment options. Medicine (Baltimore). 2023;102(38):e35237. doi: 10.1097/MD.0000000000035237.

Aygun B, Odame I. A global perspective on sickle cell disease. Pediatr Blood Cancer. 2022;59(2):386-90. doi: 10.1002/pbc.24175.

Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561-73. doi: 10.1056/NEJMra1510865.

Houwing ME, de Pagter PJ, van Beers EJ, Biemond BJ, Rettenbacher E, Rijneveld AW, et al. Sickle cell disease: Clinical presentation and management of a global health challenge. Blood Rev. 2019;37:100580.doi: 10.1016/j.blre.2019.05.004.

Mangla A, Agarwal N, Maruvada S. Sickle Cell Anemia. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.

Tebbi CK. Sickle cell disease, a review. Haematology. 2022;3(2):341-66.doi: 10.3390/hemato3020024.

Inusa BPD, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, et al. Sickle cell disease—Genetics, pathophysiology, clinical presentation and treatment. Int J Neonatal Screen. 2019;5(2):20-31. doi: 10.3390/ijns5020020.

Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010. doi: 10.1038/nrdp.2018.10.

Adigwe OP, Onavbavba G, Onoja SO. Impact of sickle cell disease on affected individuals in Nigeria: A critical review. Int J Gen Med. 2023;16:3503-15. doi: 10.2147/IJGM.S410015.

Stephen N, Nden N, Gusen NJ, Kumzhi P, Gaknung BK, Auta D, et al. Prevalence of sickle cell disease among children attending Plateau Specialist Hospital, Jos, Nigeria. Acta Med Int. 2018;5:20-3. doi:10.4103/ami.ami_60_17.

Naing L, Nordin RB, Abdul Rahman H, Naing YT. Sample size calculation for prevalence studies using Scalex and ScalaR calculators. BMC Med Res Methodol. 2022 ;22(1):209. doi: 10.1186/s12874-022-01694-7.

Taiwo IA, Oloyede OA, Dosumu AO. Frequency of sickle cell genotype among the Yorubas in Lagos: Implications for the level of awareness and genetic counseling for sickle cell disease in Nigeria. J Community Genet. 2011;2(1):13-8. doi: 10.1007/s12687-010-0033-x.

Diwe K, Iwu AC, Uwakwe K, Duru C, Merenu I, Ogunniyan T, et al. Prevalence and patterns of sickle cell disease among children attending tertiary and non-tertiary health care institutions in a South Eastern State, Nigeria: A 10-year survey. J Res Med Dent Sci. 2016;4(3):183-9. doi: 10.5455/jrmds.2016432.

Hockham C, Bhatt S, Colah R, Mukherjee MB, Penman BS, Gupta S, et al. The spatial epidemiology of sickle-cell anemia in India. Sci Rep. 2018;8(1):17685. doi: 10.1038/s41598-018-36077-w.

Brandow AM, Liem RI. Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol. 2022;15(1):20. doi: 10.1186/s13045-022-01237-z.

Gaur M, Sehgal T. Reticulocyte count: a simple test but tricky interpretation! Pan Afr Med J. 2021;40:3. doi: 10.11604/pamj.2021.40.3.31316.

Rai D, Wilson AM, Moosavi L. Histology, reticulocytes. Florida, USA: StatPearls Publishing; 2023.

Das J, Khonglah Y, Tiewsoh I, Chowdhury Z, Barman H. Utility of reticulocyte indices in the diagnosis of pancytopenia. J Fam Med Prim Care. 2022;11(4):1335-40. doi: 10.4103/jfmpc.jfmpc_1121_21.

Piva E, Brugnara C, Spolaore F, Plebani M. Clinical utility of reticulocyte parameters. Clin Lab Med. 2015;35(1):133-63. doi: 10.1016/j.cll.2014.10.004.

Nwabuko ON, Onwuchekwa U, Iheji O. An overview of sickle cell disease from the socio-demographic triangle: A Nigerian single-institution retrospective study. Pan Afr Med J. 2022;41:161. doi: 10.11604/pamj.2022.41.161.27117.

Odièvre MH, Verger E, Silva-Pinto AC, Elion J. Pathophysiological insights in sickle cell disease. Indian J Med Res. 2011;134(4):532-7.

Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018-31. doi: 10.1016/S0140-6736(10)61029-X.

Santos FK, Maia CN. Patients with sickle cell disease taking hydroxyurea in the Hemocentro Regional de Montes Claros. Rev Bras Hematol Hemoter. 2011;33(2):105-9. doi: 10.5581/1516-8484.20110029.

Carden MA, Fasano RM, Meier ER. Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia. Blood Rev. 2020;40: 100637. doi: 10.1016/j.blre.2019.100637.

Janus J, Moerschel SK. Evaluation of anemia in children. Am Fam Physician. 2010;81(12):1462-71.

Sani MA, Adewuyi JO, Babatunde AS, Olawumi HO, Shittu RO. The iron status of sickle cell anaemia patients in Ilorin, North Central Nigeria. Adv Hematol. 2015:2015:386451. doi: 10.1155/2015/386451.

Akingbola TS, Ezekekwu CA, Yaria J, Saraf SL, Hsu LL, Cooper R, et al. Assessment of bone marrow function in sickle cell anaemia patients using corrected reticulocyte counts. Blood. 2015;126(23): 4581. doi: 10.1182/blood.V126.23.4581.4581

Kaushal M, Byrnes C, Khademian Z, Duncan N, Luban NL, Miller JL et al. Examination of reticulocytosis among chronically transfused children with sickle cell anemia. PLoS One. 2016;11(4): e0153244.doi: 10.1371/journal.pone.0153244.

Candar Ö, Ekinci Ö, Doğan A, Ebinç S. Do mean platelet volume and platelet count vary on a daily or gender basis? J Curr Hematol Oncol Res. 2024;2(1):6-9. doi: 10.51271/JCHOR-0027.

Jeremiah Z, Magnus A. Elevated mean cell volume in sickle cell anaemia: One story, too many? Sanamed. 2024;19(1): 51–7. doi: 10.5937/sanamed19-49277.

Akodu SO, Njokanma OF, Adeolu-Kehinde O. Erythrocyte indices in preschool Nigerian children with sickle cell anaemia in steady state. Int J Hematol Oncol Stem Cell Res. 2015;9(1):5-9.

Kabuyi PL, Mbayabo G, Ngole M, Zola AL, Race V, Matthijs G, et al. Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa. EJHaem. 2023;4(3):595-601. doi: 10.1002/jha2.735.

Ofakunrin AO, Oguche S, Adekola K, Okpe ES, Afolaranmi TO, Diaku-Akinwumi IN, et al. Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria. J Trop Pediatr. 2020;66(3):290-8. doi: 10.1093/tropej/fmz070.

Amarendar S, Chandra S, Karedla S, Jyothi AK, Gupta D, Jagadale KA. Optimizing hematological profiles and reducing vaso-occlusive crises: hydroxyurea therapy’s impact on complete blood count parameters in sickle cell disease patients. Journal of Population Therapeutics and Clinical Pharmacology.2024; 31(6): 2041-57. doi:10.53555/jptcp.v31i6.6768.

Parodi E, Romano F, Ramenghi U. How we use reticulocyte parameters in workup and management of pediatric hematologic diseases. Front Pediatr. 2020;8:588617.doi: 10.3389/fped.2020.588617.

López Rubio M, Argüello Marina M. The current role of hydroxyurea in the treatment of Sickle Cell Anemia. J Clin Med. 2024;13(21):6404. doi: 10.3390/jcm13216404.

Khargekar N, Banerjee A, Athalye S, Mahajan N, Kargutkar N, Tapase P, et al. Role of hydroxyurea therapy in the prevention of organ damage in Sickle Cell Disease: a systematic review and meta-analysis. Syst Rev. 2024;13(1):60. doi: 10.1186/s13643-024-02461-z.